Business Wire

LIXIL-JS-FOUNDATION

27.7.2016 07:14:00 CEST | Business Wire | Press release

Share
"The 6th LIXIL International Student Architectural Competition" Seeking and Reviewing Next-generation Sustainable Housing Technology; "INFINITE FIELD" by Royal Danish Academy of Fine Arts (Denmark) Wins Top Prize

The LIXIL JS Foundation (located in Koto-ku, Tokyo; Chairperson: Yoko Ushioda), which facilitates surveys and research related to the housing and building materials industries as well as supporting the development of human resources, conducted the Open Final Screening for the 6th LIXIL International Student Architectural Competition at the Keidanren Kaikan (Chiyoda-ku, Tokyo) on July 20, 2016 (Wed). The purpose of the competition is to seek and review next-generation sustainable housing technology and communicate that technology to the global society. The top three universities chosen from twelve participating universities in ten countries gave presentations, and INFINITE FIELD by Royal Danish Academy of Fine Arts (Denmark) was selected as the winner.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160726006668/en/

During the Open Final Screening, a heated discussion occurred between the head of jury, Kengo Kuma (Architect/ Professor, the University of Tokyo) and jurors, Tomonari Yashiro (Professor, Institute of Industrial Science, the University of Tokyo/ Vice President, the University of Tokyo), Masato Araya (Structural Designer/ Professor Emeritus, Waseda University), Yoshiharu Tsukamoto (Architect/ Co-founder of Atelier Bow-Wow/ Professor, Graduate school of Tokyo Institute of Technology) and Dana Buntrock (Architect, Department of Architecture, University of California, Berkeley). The theme of the 6th competition was “Comfort and Lightness.” As the competition’s first attempt, the contestants proposed a light shelter, which can be easily assembled and moved. This time around, as another first attempt, their mockups were actually brought in and exhibited at the hall for the final screening.

Royal Danish Academy of Fine Arts’ INFINITE FIELD was highly rated in various aspects, including a whole new architectural approach that can safely be referred to as an extension of “furniture” that gives consideration even to the form created by the human body and wood, a high degree of perfection of details, including materials to be cut and assembled, and a 360 degree open design that can become a big appeal when installed in Taiki-cho, Hokkaido.

In his general comments, the head juror, Kengo Kuma said, “Screening by using mockups was something innovative that I had never experienced and it gave the students a good opportunity to think about architecture starting with materials. Moreover, this competition was valuable also from a perspective of architectural culture in that their work remains.” At the award ceremony, Mr. Konstatinos Fetsis of Royal Danish Academy of Fine Arts commented, “I am very pleased to have been able to take part in this competition and this journey with these members. This has become such a wonderful experience that I will never forget as a student who majors in architecture.”

With support from Kengo Kuma & Associates, the team will arrive at a final design for “INFINITE FIELD,” and the project is scheduled to be built in October 2016 on a site at Memu Meadows, located in Taiki-cho, Hokkaido.

[Reference Information]
List of Winning Works
- Top Prize 
INFINITE FIELD by Royal Danish Academy of Fine Arts

- Award of Excellence (2 works)
LEVITATING ATMOSPHERES by HESAM University / ENSA Paris-La-Villette
Light Skin HOUSE by Yokohama National University

6th LIXIL International Student Architectural Competition
Theme: Comfort and Lightness
The contemporary concept of comfort hinges on blocking out the environment and creating barriers. But perhaps what we really need today is to live in closer proximity to nature. Please design a light shelter, one which can be easily assembled and moved, and also allows residents to enjoy a comfortable life. The ability to move the house means interpreting, considering, and creating a relationship with its surroundings. And the ability to easily assemble means it can become linked with the natural environment and ground, and draw out the richness of the place. Please devise a house that can be easily assembled and moved, and will allow the residents to enjoy the environment, both the summer and winter in Taiki-cho, Hokkaido. The relationship with nature and the surrounding area in your proposal might also include a method of interpreting the environment if the house was relocated to a city.

1. Participating universities: 12 universities in 10 countries
* The three universities marked with X proceeded to the Open Final Screening held on July 20, 2016.

  Cornell University (USA)
Parsons School of Design (USA)
Universidad Nacional Autónoma de México (México)

X

Royal Danish Academy of Fine Arts (Denmark)

Polytechnic of Milan (Italy)

X

HESAM University / ENSA Paris-La-Villette (France)

Swiss Federal Institute of Technology (ETH) Zurich (Switzerland)
University of Melbourne (Australia)
Chulalongkorn University (Thailand)
University of Cape Town (South Africa)
Kyoto Institute of Technology (Japan)

X

Yokohama National University (Japan)

 

2. Judging method
Twelve universities in ten countries were invited to submit proposals for a next-generation, sustainable house designed for a cold region. Three entrants were then selected in the first screening (based on documents submitted). The top prize winner was subsequently chosen in the Open Final Screening.

3. Jury:
Kengo Kuma (Professor at the Graduate School of Architecture, The University of Tokyo)
Tomonari Yashiro (Deputy Director and Professor at the Institute of Industrial Science, The University of Tokyo)
Masato Araya (Structural Engineer, Professor Emeritus at Waseda University)
Yoshiharu Tsukamoto (Professor at Tokyo Institute of Technology, Co-Principal of Atelier Bow-Wow)
Dana Buntrock (Professor at Department of Architecture, University of California, Berkeley)

4. Prizes
Top prize (one work): $15,000 (USD; including design fee)
Award of Excellence (two works): $3,000

*The winner’s work “INFINITE FIELD” will be built on a site at Memu Meadows, located in Taiki-cho, Hokkaido (to be completed in October 2016).

Contact:

LIXIL JS Foundation
Kumeo Takahata, +81(0)3-5626-1008
2-1-1, Oshima, Koto-ku, Tokyo 136-8535
LIXIL JS Foundation website: http://www.lixiljsfound.com/

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye